Increased Expression of Osteopontin in the Heart Tissue of Lewis Rats with Experimental Autoimmune Myocarditis
Authors:
Open Access
- 1 January 2006
- journal article
- Published by Japanese Society of Veterinary Science in Journal of Veterinary Medical Science
- Vol. 68 (4) , 379-382
Abstract
The expression of osteopontin (OPN) in the hearts of rats with experimental autoimmune myocarditis (EAM) was evaluated. Western blot analysis showed that OPN was significantly increased in the hearts with EAM compared with those of complete Freund's adjuvant (CFA) immunized control. Immunohistochemically, OPN was weakly expressed in the cardiomyocytes in the heart with normal and CFA immunized controls. In EAM lesions, OPN was intensely immunostained in some inflammatory cells, mainly ED1 positive macrophages. These findings suggest that OPN is significantly increased in EAM lesions and that OPN mediates the inflammatory process in the course of rat EAM model.Keywords
This publication has 9 references indexed in Scilit:
- Osteopontin Inhibits Interleukin-1β-stimulated Increases in Matrix Metalloproteinase Activity in Adult Rat Cardiac FibroblastsJournal of Biological Chemistry, 2003
- Time course of gene expression in rat experimental autoimmune myocarditisClinical Science, 2002
- Levels of MCP-1 and GM-CSF mRNA Correlated with Inflammatory Cytokines mRNA Levels in Experimental Autoimmune Myocarditis in RatsAutoimmunity, 2002
- Osteopontin Is a Negative Feedback Regulator of Nitric Oxide Synthesis in Murine MacrophagesThe Journal of Immunology, 2001
- An inhibitor of inducible nitric oxide synthase ameliorates experimental autoimmune myocarditis in Lewis ratsJournal of Neuroimmunology, 1998
- Myocardial Osteopontin Expression Is Associated With Left Ventricular HypertrophyCirculation, 1997
- Receptor-Ligand Interaction Between CD44 and Osteopontin (Eta-1)Science, 1996
- Osteopontin: a protein with diverse functionsThe FASEB Journal, 1993
- A novel experimental model of giant cell myocarditis induced in rats by immunization with cardiac myosin fractionClinical Immunology and Immunopathology, 1990